Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia

被引：54
|
作者：
Keating, Amy K. [1 ,2 ]
Gossai, Nathan [3 ]
Phillips, Christine L. [4 ,5 ]
Maloney, Kelly [1 ,2 ]
Campbell, Kristen [1 ,2 ]
Doan, Andrew [6 ]
Bhojwani, Deepa [7 ]
Burke, Michael J. [7 ]
Verneris, Michael R. [1 ,2 ]
机构：
[1] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA
[2] Childrens Hosp Colorado, Aurora, CO USA
[3] Childrens Minnesota, Minneapolis, MN USA
[4] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[5] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[6] Childrens Hosp Los Angeles, Keck Sch Med USC, Los Angeles, CA 90027 USA
[7] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA
来源：
BLOOD ADVANCES | 2019年 / 3卷 / 13期
关键词：
THERAPY;
D O I：
10.1182/bloodadvances.2018025726
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1926 / 1929
页数：4
相关论文
共 50 条
  • [31] Detection and management of minimal residual disease in acute lymphoblastic leukemia
    Schrappe, Martin
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 244 - 249
  • [32] THE DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA
    POTTER, MN
    BLOOD REVIEWS, 1992, 6 (02) : 68 - 82
  • [33] THE STUDY OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA
    KNECHTLI, CJC
    GOULDEN, NJ
    LANGLANDS, K
    POTTER, MN
    JOURNAL OF CLINICAL PATHOLOGY-CLINICAL MOLECULAR PATHOLOGY EDITION, 1995, 48 (02): : M65 - M73
  • [34] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA
    ROBERTS, WM
    ESTROV, Z
    ZIPF, TF
    BLOOD, 1995, 86 (03) : 1237 - 1238
  • [35] Minimal residual disease quantification in adult acute lymphoblastic leukemia
    Heather Landau
    Mark A. Weiss
    Current Oncology Reports, 2006, 8 (5) : 323 - 324
  • [36] MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    CARR, T
    STEVENS, RF
    LANCET, 1994, 343 (8891): : 190 - 190
  • [37] Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia
    Sitthi-Amorn, Jitsuda
    Herrington, Betty
    Megason, Gail
    Pullen, Jeanette
    Gordon, Catherine
    Hogan, Shirley
    Koganti, Tejaswi
    Hicks, Chindo
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2015, 9 : 51 - 60
  • [38] Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia
    Ceppi, Francesco
    Rizzati, Frida
    Colombini, Antonella
    Conter, Valentino
    Cazzaniga, Giovanni
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (09) : 795 - 807
  • [39] NGS of immunoglobulin genes rearrangements for diagnostics of minimal residual disease in pediatric acute lymphoblastic leukemia
    Miroshnichenkova, A.
    Komkov, A.
    Zerkalenkova, E.
    Nugmanov, G.
    Mamedov, I.
    Popov, A.
    Olshanskaya, Y.
    Maschan, M.
    FEBS OPEN BIO, 2018, 8 : 299 - 300
  • [40] Prospects for Minimal Residual Disease as a Surrogate Endpoint in Pediatric Acute Lymphoblastic Leukemia Clinical Trials
    McShane, Lisa M.
    Smith, Malcolm A.
    JNCI CANCER SPECTRUM, 2018, 2 (04)
12345